Share
Preview
April 2019 News from Champions Oncology

Covering a full range of research and development solutions that help guide decision making for clinical oncology drug development, here's where you can stay up-to-date on news, events, and special opportunities for study enrollment.

INTRODUCING CHAMPIONS KNOWLEDGEBASE

Explore our newly-developed Champions KnowledgeBase. Based on whole-exome and RNA sequencing data, the KnowledgeBase is a resource and information repository where PDX models are now grouped and sorted according to shared genomic features and activities within defined molecular and cellular pathways.

Accessible from the Champions database welcome page, the KnowledgeBase now enables you to more readily evaluate Champions PDX models for deployment into your specific discovery, pre-clinical, and clinical-stage therapeutic programs.


















ENROLLING MAY 1st, 2019 - BREAST CANCER 3-D EX VIVO SCREEN


We are proud to launch are initial offering in our 3-D Ex Vivo PDX screen utilizing the Cypre VersaGel Platform.

Enroll 15 or 30 Breast Cancer PDX models across all subtypes with available genomic and treatment response data. Find out more details here


















DOWNLOAD OUR AACR 2019 EX VIVO AML POSTER PRESENTATION


Champions' AML Ex Vivo Platform poster presented at AACR 2019 in Atlanta is now available for download.

Find our more about this platform and its utility in evaluating activity of novel therapeutic agents by downloading the presentation here


ANNOUNCING CHAMPIONS INAUGURAL UK ONCOLOGY DRUG DISCOVERY SYMPOSIUM - 12th June, 2019


Topics Include:

- Organoid 2.0: towards in vitro oncology trials
- How to optimise the use of PDX models to run effective in vivo pre-clinical trials
- Next-generation humanised mouse models for immuno-oncology
- Novel approaches to targeting immunosuppression in cancer

Find our more information here
Please contact Chris Noakes today at cnoakes@championsoncology.com
or 858-752-4544 for more information
Copyright © 2019, All rights reserved.

Our mailing address is:
Corporate Headquarters
One University Plaza
Suite 307
Hackensack, NJ 07601

Champions TumorGraft is a registered trademark of Champions Oncology

 
 

Email Marketing by ActiveCampaign